Home » Consumer Health

205 posts categorized "Consumer Health"

October 21, 2014

Claves para descifrar el mercado de vitaminas y suplementos alimenticios en América Latina

250_consumerHealthSpanish-v1.0El mercado global de vitaminas y suplementos alimenticios está en auge y América Latina destaca por el dinamismo en la venta de estos productos. Se espera que el aumento en la demanda continúe, atrayendo mayor competencia y aumentando el valor de la industria a US$5,5 mil millones para el año 2018.

Descarga-Ahora

Descarga este e-book para obtener un panorama global del mercado de vitaminas y suplementos alimenticios así como las principales tendencias en Argentina, Bolivia, Brasil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, México, Perú, República Dominicana, Uruguay y Venezuela.

Keys to Navigating the Vitamin and Dietary Supplement Market in Latin America

250_consumerHealth-v1.0The global vitamin and dietary supplement market is booming, and Latin America is at the forefront as one of the most dynamic consumer health markets. Increasing demand in the region is expected to continue, bringing strong competition and increasing the value of the industry to US$5.5 billion by 2018.

Download-Now

Download this e-book for a global overview of vitamins and dietary supplement market trends, as well as local strategies in Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Peru, Uruguay and Venezuela.

Key Takeaways from SupplySide West 2014

ChrisSchmidtAnalyst Insight by Chris Schmidt - Consumer Health Analyst

View Chris Schmidt's profile on LinkedIn

During the week of 6 October 2014 Euromonitor presented at SupplySide West, one of the nutrition industry’s most important global gatherings. This year’s exposition brought together more than 1,700 of the health ingredient industry’s leading companies, including formulators, manufacturers, laboratory experts and finished product producers. Euromonitor’s Consumer Health Analyst Chris Schmidt and Head of Health and Wellness Ewa Hudson delivered insights into sports nutrition and energy drinks, respectively. As in years past, SupplySide West provided a comprehensive overview of the industry’s most important trends and developments, including the product and market developments, new technologies and regulatory changes that are likely to drive the industry moving forward.

Continue reading "Key Takeaways from SupplySide West 2014" »

September 30, 2014

Euromonitor to Speak at CPhI Worldwide

CPHI WW

Event Name: CPhI Worldwide

Date: 6-9th October, 2014

Location: Paris, France

Event Description: CPhI Worldwide hosts 2,500 exhibitors and 35,000 attendees from 140 countries. Meet face-to-face with international pharmaceutical companies, stay informed about the latest industry trends and remain one step ahead of a constantly changing pharmaceutical market.

Link: http://www.cphi.com/ 

Pre-Connect Congress: 6th October http://www.cphi.com/europe/agenda/pre-connect-congress

 

Continue reading "Euromonitor to Speak at CPhI Worldwide" »

September 4, 2014

Snapshots of GlaxoSmithKline’s Consumer Healthcare Division and Horlicks’ Sales

Hope.LeeAnalyst Insight by Hope Lee - Senior Beverages Analsyt

The bribery case in China and disappointing second-quarter results have put GlaxoSmithKline (GSK) in the headlines again. The pharmaceutical giant was initially reported to be looking to spin off its Consumer Healthcare division and make it a stand-alone company – but GSK quickly denied any such plans. Simon Steel, GSK’s spokesman, later stated that GSK would not rule out the possibility of one day divesting the unit, but that it is not currently being considered, at least in the short term. The quick denial raised interest in the media and among analysts as to what exactly GSK plans to do with the consumer unit and a decision about the future of Horlicks in the long term.

 

Horlicks JPEG.jpg

 

Continue reading "Snapshots of GlaxoSmithKline’s Consumer Healthcare Division and Horlicks’ Sales" »

August 29, 2014

Prospects for the GSK and Novartis Consumer Health Joint Venture

GSK Novartis global value map

In April 2014, GlaxoSmithKline Plc and Novartis AG announced plans to create a consumer health joint venture to be completed in the first half of 2015. Their extensive global presence and range of top-selling consumer health brands have the potential to establish the partnership as the new industry leader. Pending approvals, the joint venture will be a powerhouse in over-the-counter remedies and hold a commanding market share of analgesics, NRT smoking cessation aids, dermatologicals and more.

August 27, 2014

Strategy Briefing: Opportunities and Challenges in Global Participatory Sport

250_particSport-v1.1According to our new report, health and vanity have been the two largest influencers on consumer exercise.  Obesity has been identified largely as a public health issue due to excessive amounts of media coverage. Therefore, governments around the world have started many initiatives to encourage consumers to exercise more.  Some have even increased funding for public sports facilities or provided tax incentives. 

Download-Now-finalDescarga-Ahora

 

 

 

Physical attractiveness has also been an important aspect of exercise, as mass media applies much pressure on the consumer to appear perfect, with many ads featuring airbrushed models.  This aspirational perfectionism has not only fuelled interest in exercise but has also increased body disorders, which have also risen over the past decade.

Some of the latest popular exercises include extreme sports such as rock climbing and adventure sports such as triathlons. Many health clubs continued to see growth in developed countries as well, even in spite of the recession.

The increased participation in exercise has led to marketing opportunities and product success in many industries, particularly apparel.  Sportswear sales have consistently outperformed the wide apparel market over recent years, with outdoor clothing becoming popular. 

“There are many market opportunities within apparel, health and supplements, sports and energy drinks, and electronics to cater to the exercise and health conscious consumer,” says Editorial Director, Gina Westbrook.  “Our report really highlights opportunities and challenges globally within exercise and sports consumption.”

Continue reading "Strategy Briefing: Opportunities and Challenges in Global Participatory Sport" »

August 25, 2014

Ireland's Thriving Pharmaceutical Industry

Ireland is a global leader in research, development and innovation, and with government investment and support, is likely to remain a leader for some time. The success of the pharmaceutical industry in Ireland is a result of these investments, with pharmaceutical exports from Ireland reaching US$39 billion in 2013. Ireland’s young workforce, favorable tax environment and experience working with multinational companies means the pharmaceutical industry is poised for success in the future as well.

Watch on Youtube

August 10, 2014

Closure of Window for Tax Inversion Might Not Deter Pharma Giants from Acquiring Peers

Jana DranenkaiteAnalyst Insight by Jana Dranenkaite - Industrial Research Manager

View Jana Dranenkaite's profile on LinkedIn

American pharmaceutical and medical device players are proactively seeking to acquire their global competitors. However, with recent deals pending, the American government is planning to implement controversial corporate tax reform. Changing domicile to save on taxes is the primary motivator, but there are also other advantages to rebasing, so that merger and acquisition activity might therefore be more muted, but not killed in the years to come.

Encouraged by a reluctance to pay high corporate taxes in the US market, tax inversion is the hottest financial savings instrument of the moment. The recent acquisition of Shire by AbbVie, labelled as the biggest tax inversion deal ever, and seven more deals this year, are pending as the US government seeks to curb the relocation mania.

Continue reading "Closure of Window for Tax Inversion Might Not Deter Pharma Giants from Acquiring Peers" »

Pharmacies and Drug Stores Using M-Commerce to Grow Sales

Pharmacies and drug stores are increasingly using the power of m-commerce to grow sales. For instance, Asian pharmacy chain Watsons uses a mobile app to communicate with consumers about health and beauty tips and send coupons. For other pharmacies, m-commerce is a platform to enter new markets, such US-based Vitamin Shoppe. The chain's partnership with Indian internet retailer Healthkart.com is allowing Vitamin Shoppe to expand to the country without an actual physical presence.

Watch 0n Youtube

Subscribe

 RSS Feed

Receive New Posts via Email:

 

Join us on...


View our YouTube Channel Follow Euromonitor on Twitter Become a Fan on Facebook Connect with Euromonitor on LinkedIn




Filter by Category

Filter by Geography

Filter by Industry

Recent Posts

Claves para descifrar el mercado de vitaminas y suplementos alimenticios en América Latina

Keys to Navigating the Vitamin and Dietary Supplement Market in Latin America

Key Takeaways from SupplySide West 2014

Euromonitor to Speak at CPhI Worldwide

Snapshots of GlaxoSmithKline’s Consumer Healthcare Division and Horlicks’ Sales

Prospects for the GSK and Novartis Consumer Health Joint Venture

Strategy Briefing: Opportunities and Challenges in Global Participatory Sport

Ireland's Thriving Pharmaceutical Industry

Closure of Window for Tax Inversion Might Not Deter Pharma Giants from Acquiring Peers

Pharmacies and Drug Stores Using M-Commerce to Grow Sales